UK's Diaceutics H1 revenue rises, gross margin expands
UK's Diaceutics H1 revenue rises, gross margin expands
Overview
UK diagnostic commercialization firm's H1 revenue rose 20% yr/yr to £17.5 mln
Annual recurring revenue up 79% and gross margin expanded to 85%
Order book rose 38% to £43.7 mln, with positive free cash flow
Outlook
Company says delivered revenue, contracted revenue and pipeline provide 107% visibility on FY 2026 median analyst consensus revenue estimates
Diaceutics says Board remains confident in delivering against its 2026 expectations
Company expects higher weighting of revenue and profitability in H2 2026
Result Drivers
RECURRING REVENUE GROWTH - Co said 79% increase in annual recurring revenue and higher net revenue retention were driven by deeper customer relationships, broader adoption of its services, and improved account planning
EXPANSION INTO NEW MARKETS - Co said its 'Precision For All' strategy expanded its addressable market and contributed to revenue growth, with 22% of H1 revenue from new diagnostic-driven therapy brands
OPERATIONAL EFFICIENCY - Co said automation and AI-enabled workflows reduced data processing costs and supported margin expansion as revenue scaled
Company press release: ID:nRSV6621Va
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
H1 Revenue |
| GBP 17.46 mln |
|
H1 Gross Margin |
| 85.00% |
|
H1 Gross Profit |
| GBP 14.86 mln |
|
H1 Order Backlog |
| GBP 43.68 mln |
|
H1 Pretax Loss |
| GBP 3.97 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the business support services peer group is "buy"
Wall Street's median 12-month price target for Diaceutics PLC is GBp215.00, about 26.5% above its September 21 closing price of GBp170.00
The stock recently traded at 60 times the next 12-month earnings vs. a P/E of 70 three months ago
Reuters Recommended Reads
Sept 21 - UK's Invinity H1 revenue rises on project deliveries
Sept 21 - UK's B90 Holdings H1 revenue rises 38%, net loss narrows
Sept 21 - UK's Getech H1 revenue rises on Globe subscription renewal
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)